Allspring Global Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Allspring Global Investments's XBI Position: Q1 2026 in Review
Allspring Global Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 60% in Q1 2026, selling an estimated $13.2M and leaving 71,538 shares worth $9.2M. The position accounts for 0.02% of the portfolio, ranked #713.
Allspring Global Investments first reported a position in XBI in Q4 2021 and has held it in 18 quarters since. The position peaked at $24.3M in Q3 2025. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Allspring Global Investments held 71,538 shares of State Street SPDR S&P Biotech ETF worth $9.2M as of Q1 2026.
- Allspring Global Investments sold 105,474 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $13.2M.
- State Street SPDR S&P Biotech ETF made up 0.02% of Allspring Global Investments's portfolio in Q1 2026, its #713 holding.
- Allspring Global Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's State Street SPDR S&P Biotech ETF position peaked at $24.3M in Q3 2025.
- 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.